相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of Different Scoring Systems in the Assessment of Estrogen Receptor Status for Predicting Prognosis in Endometrial Cancer
Yue Wang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)
A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers
Vit Weinberger et al.
FRONTIERS IN ONCOLOGY (2019)
Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review
Willem Jan van Weelden et al.
FRONTIERS IN ONCOLOGY (2019)
The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification
Jun Guan et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study
Louis J. M. van der Putten et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Tissue microarray is suitable for scientific biomarkers studies in endometrial cancer
Nicole C. M. Visser et al.
VIRCHOWS ARCHIV (2018)
Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis
Josee-Lyne Ethier et al.
GYNECOLOGIC ONCOLOGY (2017)
Integrated genomic and molecular characterization of cervical cancer
Robert D. Burk et al.
NATURE (2017)
Association of body mass index with ER, PR and 14-3-3σ expression in tumor and stroma of type I and type II endometrial carcinoma
Joseph F. Peevey et al.
ONCOTARGET (2017)
Comparison of Estrogen and Progesterone Receptor Antibody Reagents Using Proficiency Testing Data
Megan L. Troxell et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
Anthony N. Karnezis et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2017)
Confirmation of ProMisE: A Simple, Genomics-Based Clinical Classifier for Endometrial Cancer
Aline Talhouk et al.
CANCER (2017)
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
Louis J. M. van der Putten et al.
BRITISH JOURNAL OF CANCER (2016)
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts
Ellen Stelloo et al.
CLINICAL CANCER RESEARCH (2016)
Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer
Anthony E. Rizzardi et al.
DIAGNOSTIC PATHOLOGY (2016)
A clinically applicable molecular-based classification for endometrial cancers
A. Talhouk et al.
BRITISH JOURNAL OF CANCER (2015)
Which threshold for ER positivity? a retrospective study based on 9639 patients
M. Yi et al.
ANNALS OF ONCOLOGY (2014)
Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions
Ingvild Loberg Tangen et al.
EUROPEAN JOURNAL OF CANCER (2014)
Lack of Estrogen Receptor-α Is Associated with Epithelial-Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
Elisabeth Wik et al.
CLINICAL CANCER RESEARCH (2013)
Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial
Jone Trovik et al.
EUROPEAN JOURNAL OF CANCER (2013)
Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma
Jutta Huvila et al.
GYNECOLOGIC ONCOLOGY (2013)
The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer
Gian Franco Zannoni et al.
HUMAN PATHOLOGY (2013)
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
C. Krakstad et al.
BRITISH JOURNAL OF CANCER (2012)
Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients
Kentaro Tamaki et al.
CANCER SCIENCE (2010)
Prognostic significance and clinical importance of estrogen receptor α and β in human endometrioid adenocarcinomas
Ioannis Mylonas
ONCOLOGY REPORTS (2010)
Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer
Vincent Jongen et al.
GYNECOLOGIC ONCOLOGY (2009)
Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
Meenakshi Singh et al.
GYNECOLOGIC ONCOLOGY (2007)
Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer
GB Mann et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms
OM Conneely et al.
STEROIDS (2003)
Estrogen and progesterone receptor assay in paraffin-embedded breast cancer - Reproducibility of assessment
G Chebil et al.
ACTA ONCOLOGICA (2003)
Theories of endometrial carcinogenesis: A multidisciplinary approach
ME Sherman
MODERN PATHOLOGY (2000)
分享论文
